Enhancer ID: | E_02_0250 |
Species: | human |
Position : | chr15:45089423-45091423 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Congenital hypothyroidism |
Pubmed ID: | 30651277 |
Enhancer experiment: | PCR, Western blot, sequencing technology |
Enhancer experiment description: | This mutation, located within an exonic splicing enhancer motif, caused aberrant splicing of DUOX2 transcripts and resulted in lower H2O2 production, which might cause a severe defect in thyroid hormone production. |
Target gene : | DUOX2 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | This mutation, located within an exonic splicing enhancer motif, caused aberrant splicing of DUOX2 transcripts and resulted in lower H2O2 production, which might cause a severe defect in thyroid hormone production. |
TF name : | -- |
TF experiment: | PCR?Western blot????? |
TF experiment description: | This mutation, located within an exonic splicing enhancer motif, caused aberrant splicing of DUOX2 transcripts and resulted in lower H2O2 production, which might cause a severe defect in thyroid hormone production. |
Enhancer function : | This mutation, located within an exonic splicing enhancer motif, caused aberrant splicing of DUOX2 transcripts and resulted in lower H2O2 production, which might cause a severe defect in thyroid hormone production. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
This mutation, located within an exonic splicing enhancer motif, caused aberrant splicing of DUOX2 transcripts and resulted in lower H2O2 production, which might cause a severe defect in thyroid hormone production. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|